Jerry S. Lanchbury - 14 Jan 2022 Form 4 Insider Report for MYRIAD GENETICS INC (MYGN)

Role: Officer
Signature: By: Nathan A. Smith For: Jerry S. Lanchbury
Issuer symbol: MYGN
Transactions as of: 14 Jan 2022
Net transactions value: $0
Form type: 4
Filing time: 18 Jan 2022, 16:02:50 UTC
Previous filing: 12 Oct 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	MYGN	Common Stock						264,324	14 Jan 2022	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Jerry S. Lanchbury is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Remarks:

Mr. Lanchbury's title is Former Chief Scientific Officer This "Exit" Form 4 is voluntarily filed to report solely that the Reporting Person is no longer serving in the role as the Company's Chief Scientific Officer, effective as of January 14, 2022, and therefore is no longer subject to Section 16 reporting